Get started
Author

Laura Semenzato

Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people
2021 · Laura Semenzato, Jérémie Botton, et al. · The Lancet Regional Health - Europe · 261
Antihypertensive Drugs and COVID-19 Risk: A Cohort Study of 2 Million Hypertensive Patients
2021 · Laura Semenzato, Jérémie Botton, et al. · Hypertension · 118
Long-Term Prognosis of Patients With Myocarditis Attributed to COVID-19 mRNA Vaccination, SARS-CoV-2 Infection, or Conventional Etiologies
2024 · Laura Semenzato, Stéphane Le Vu, et al. · JAMA · 55
PDF
COVID-19 Hospitalization in Solid Organ Transplant Recipients on Immunosuppressive Therapy
2023 · Epiphane Kolla, Alain Weill, et al. · JAMA Network Open · 44
PDF
Risk of Guillain-Barré Syndrome Following COVID-19 Vaccines: A Nationwide Self-Controlled Case Series Study
2023 · Stéphane Le Vu, Marion Bertrand, et al. · Neurology · 36
PDF
Characteristics associated with the residual risk of severe COVID-19 after a complete vaccination schedule: A cohort study of 28 million people in France
2022 · Laura Semenzato, Jérémie Botton, et al. · The Lancet Regional Health - Europe · 36
PDF
Effectiveness of BNT162b2, mRNA-1273, and ChAdOx1-S vaccines against severe covid-19 outcomes in a nationwide mass vaccination setting: cohort study
2022 · Kim Bouillon, Bérangère Baricault, et al. · BMJ Medicine · 35
PDF
Risk of severe COVID‐19 in patients treated with IBD medications: a French nationwide study
2021 · Antoine Meyer, Laura Semenzato, et al. · Alimentary Pharmacology & Therapeutics · 33
COVID-19 mRNA Vaccination and 4-Year All-Cause Mortality Among Adults Aged 18 to 59 Years in France
2025 · Laura Semenzato, Stéphane Le Vu, et al. · JAMA Network Open · 28
PDF
N ‐nitrosodimethylamine‐Contaminated Valsartan and Risk of Cancer: A Nationwide Study of 1.4 Million Valsartan Users
2022 · Imène Mansouri, Jeremie Botton, et al. · Journal of the American Heart Association · 28
PDF
Influence of mRNA Covid-19 vaccine dosing interval on the risk of myocarditis
2024 · Stéphane Le Vu, Marion Bertrand, et al. · Nature Communications · 22
PDF
Association of Statins for Primary Prevention of Cardiovascular Diseases With Hospitalization for COVID‐19: A Nationwide Matched Population‐Based Cohort Study
2022 · Kim Bouillon, Bérangère Baricault, et al. · Journal of the American Heart Association · 22
PDF
Effectiveness of Ad26.COV2.S Vaccine vs BNT162b2 Vaccine for COVID-19 Hospitalizations
2022 · Jérémie Botton, Laura Semenzato, et al. · JAMA Network Open · 19
PDF
First-Trimester mRNA COVID-19 Vaccination and Risk of Major Congenital Anomalies
2025 · Clément Bernard, Tom Duchemin, et al. · JAMA Network Open · 14
Vaccine effectiveness against severe COVID-19 outcomes within the French overseas territories: A cohort study of 2-doses vaccinated individuals matched to unvaccinated ones followed up until September 2021 and based on the National Health Data System
2022 · Laura Semenzato, Jérémie Botton, et al. · PLoS ONE · 14
PDF
Severe SARS-CoV-2 infection as a marker of undiagnosed cancer: a population-based study
2023 · Adeline Dugerdil, Laura Semenzato, et al. · Scientific Reports · 10
PDF
Comment on ‘Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19‘ by Konig et al. Long-term exposure to hydroxychloroquine or chloroquine and the risk of hospitalisation with COVID-19: a nationwide, observational cohort study in 54 873 exposed individuals and 155 689 matched unexposed individuals in France
2020 · Emilie Sbidian, Laetitia Penso, et al. · Annals of the Rheumatic Diseases · 10
PDF
Nicotine-replacement therapy, as a surrogate of smoking, and the risk of hospitalization with Covid-19 and all-cause mortality: a nationwide, observational cohort study in France
2020 · Mahmoud Zureik, Bérangère Baricault, et al. · medRxiv · 10
PDF
No association of low‐dose aspirin with severe COVID‐19 in France: A cohort of 31.1 million people without cardiovascular disease
2022 · Jérémie Botton, Laura Semenzato, et al. · Research and Practice in Thrombosis and Haemostasis · 9
PDF
Protection of COVID-19 Vaccination Against Hospitalization During the Era of Omicron BA.4 and BA.5 Predominance: A Nationwide Case–Control Study Based on the French National Health Data System
2023 · Laura Semenzato, Jérémie Botton, et al. · Open Forum Infectious Diseases · 8
PDF
Does Measles, Mumps, and Rubella (MMR) Vaccination Protect against COVID-19 Outcomes: A Nationwide Cohort Study
2022 · Epiphane Kolla, Alain Weill, et al. · Vaccines · 7
PDF
COVID-19 vaccination rates among pregnant women in France: A nationwide cohort study
2025 · Clément Bernard, Jérôme Drouin, et al. · Vaccine · 6
Risk of heavy menstrual bleeding following COVID-19 vaccination: A nationwide case-control study
2024 · Jérémie Botton, Marion Bertrand, et al. · Vaccine · 4
Risk factors for COVID-19 hospitalisation after booster vaccination during the Omicron period: A French nationwide cohort study
2024 · Agathe Turpin, Laura Semenzato, et al. · Journal of Infection and Public Health · 4
Medication Use in People Aged 90 Years and Older: A Nationwide Study
2025 · Lukshe Kanagaratnam, Laura Semenzato, et al. · Journal of the American Medical Directors Association · 3
PDF
Works count: 43
Citation count: 840
H-index: 14
I10-index: 18
Year
Topic
Type